APREC

APREC (Association pour la Recherche Thérapeutique Anti-Cancéreuse) is a prominent French non-profit organization dedicated to advancing cancer research and therapeutic innovation. Founded by Professor David Khayat, the organization focuses on bridging the gap between fundamental laboratory research and clinical application to improve patient outcomes. APREC supports a wide range of clinical trials and translational research projects, particularly in the fields of immunotherapy and personalized medicine. By collaborating with major hospitals and academic institutions, the association plays a critical role in the development of new oncology treatments and the optimization of existing therapeutic protocols.